A carregar...

Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses’ Health Study

PURPOSE: Ki67 is a proliferation marker commonly assessed by immunohistochemistry in breast cancer, and it has been proposed as a clinical marker for subtype classification, prognosis and prediction of therapeutic response. However, the clinical utility of Ki67 is limited by the lack of consensus on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Healey, Megan A, Hirko, Kelly A, Beck, Andrew H, Collins, Laura C, Schnitt, Stuart J, Eliassen, A. Heather, Holmes, Michelle D., Tamimi, Rulla M, Hazra, Aditi
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6995281/
https://ncbi.nlm.nih.gov/pubmed/28791482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4421-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!